Skip to content
Open access · CC-BY via OpenAlex

Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization

Ameya S Kulkarni, Sandra Aleksić, David M. Berger, Felipe Sierra, George A. Kuchel, Nir Barzilai

Aging Cell · 2022 · ▲ 132 citations

Abstract

Common chronic diseases represent the greatest driver of rising healthcare costs, as well as declining function, independence, and quality of life. Geroscience-guided approaches seek to delay the onset and progression of multiple chronic conditions by targeting fundamental biological pathways of aging. This approach is more likely to improve overall health and function in old age than treating individual diseases, by addressing aging the largest and mostly ignored risk factor for the leading causes of morbidity in older adults. Nevertheless, challenges in repurposing existing and moving newly discovered interventions from the bench to clinical care have impeded the progress of this potentially transformational paradigm shift. In this article, we propose the creation of a standardized process for evaluating FDA-approved medications for their geroscience potential. Criteria for systematically evaluating the existing literature that spans from animal models to human studies will permit the prioritization of efforts and financial investments for translating geroscience and allow immediate progress on the design of the next Targeting Aging with MEtformin (TAME)-like study involving such candidate gerotherapeutics.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/acel.13596
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Kulkarni, A.S., Aleksić, S., Berger, D.M., Sierra, F., Kuchel, G.A., &amp; Barzilai, N. (2022). Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization. <em>Aging Cell</em>. https://doi.org/10.1111/acel.13596
Vancouver
Kulkarni AS, Aleksić S, Berger DM, Sierra F, Kuchel GA, Barzilai N. Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization. Aging Cell. 2022. doi:10.1111/acel.13596.
BibTeX
@article{ameya2022Gerosc, title = {Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization}, author = {Ameya S Kulkarni and Sandra Aleksić and David M. Berger and Felipe Sierra and George A. Kuchel and Nir Barzilai}, journal = {Aging Cell}, year = {2022}, doi = {10.1111/acel.13596}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings